Deals
Sagewind Capital (Sagewind), a New York-based private equity firm, has invested in Federal Advisory Partners, a strategy consulting firm serving public and private sector organisations, and the federal healthcare market.
Financial terms of the transaction have not been disclosed.
Headquartered in Arlington, Virginia, Federal Advisory Partners has deep experience serving federal healthcare customers, including the Veterans Health Administration (VHA) and the Defense Health Agency (DHA). Founded in 2017, the company is a leader in revenue cycle management and is committed to supporting clients in their mission to efficiently provide exceptional healthcare to veterans and active-duty military.
Steven Lefkowitz,
Ropes & Gray has advised Bridgepoint, an international private assets fund management group, on its acquisition of Achilles, a global leader and partner of choice for supply chain risk and performance management. Financial terms of the deal have not been disclosed.
Over the past decade supply chain risk management has increased in complexity due to numerous environmental, social, and economic drivers. Issues such as sustainability, modern slavery and equality, diversity and inclusion, as well the increased risk of sophisticated cyber-attacks have changed the way in which supply chains need to be managed: Achilles’ solutions enable customers to mitigate risk and
Kidderminster-based skin care supplier Essentially Yours has secured GBP200,000 from the Midlands Engine Investment Fund (MEIF) West Midlands Debt Finance, managed by Maven Capital Partners (Maven), backed by the Coronavirus Business Interruption Scheme Loan (CBILS).
The firm plans to use the funding to accelerate product development and expand its marketing division, both of which form part of its ambitious growth plans which should create 11 new roles.
With its main operations in Kidderminster, Worcestershire – Essentially Yours has 20 years experience in developing research led botanical skin care products The business supplies various outlets, including beauty salons, hair salons and
EMV Capital (EMVC) invested in Cambridge-based proposed deeptech early-stage investor Martlet Capital, alongside private office Saranac Partners and other investors.
The investment enables Martlet Capital to complete the acquisition of a portfolio of 50-plus minority positions from Marshall Group, including companies in life science, healthcare, cleantech sustainability, industrial and semi-conductor technology. The total targeted investment for Martlet is at GBP22 million, providing Martlet Capital with significant firepower for further follow on and new investment opportunities.
EMV Capital is making a GBP1 million investment into Martlet Capital, and through its ‘capital light’ approach intends to syndicate a part of its initial
Delegate Connect, an end-to-end event platform, has raised AUD10 million in seed capital in its first ever funding round.
The round is one of Australia’s largest Seed rounds, and for AirTree Ventures, who led the round, it’s the biggest Seed cheque written in the fund’s history. The round also includes investment from Skip Capital, the private fund of Kim Jackson and Scott Farquhar (co-founder of Atlassian), along with investment fund TEN13. Founders of some of Australia’s top startups, including Alex Zaccaria, CEO and Founder of LinkTree, and Andrew Barnes, CEO and Founder of Go1, have also joined the oversubscribed funding
Compusoft Group, a global visual CPQ provider, has acquired Access Information Technologies (Access IT), publishers of contractERP — an ERP solution tailored to the window & door and adjacent industries.
The acquisition strengthens Compusoft’s offering to customers in the window & door industry by adding new capability to manage complex business, operational and manufacturing processes. Combined with the existing range of configuration and pricing software, Compusoft will provide an expansive solution for customers to grow and optimise their business from front-end estimation through to back-end financials.
In addition to a wider product offering, the acquisition continues to expand Compusoft’s
CGE Partners (CGE) has invested in ethiXbase, a provider of third-party risk assessment services to corporates, focusing on anti-corruption, human rights, labour, and the environment.
CGE is partnering with Leas Bachatene (CEO), Russell Potter (CFO) and Michelle Knight (Head of Operations) to back the company in its next phase of growth to become the leading global provider of supply chain risk assessment software solutions. CGE will bring significant experience and resource to support ethiXbase’s international expansion, future M&A and new product development initiatives.
Leas Bachatene, CEO of ethiXbase, comments: “ethiXbase’s mission to support organisations worldwide to adopt sustainable and socially
AUA Private Equity Partners portfolio company Westminster Pet Products, has acquired substantially all of the assets of Pet Ventures, dba Pet ‘n Shape.
Established in 2005 by the Abramson Family, Pet ‘n Shape is an emerging brand of pet treats and chews that offers a full-line of branded, high-quality products made from natural ingredients.
Joe Flanigan, CEO of Westminster, says: “The combination of Westminster and Pet ‘n Shape allows us to build on the success Pet ‘n Shape has established in the online and e-commerce channels, and enables us to serve a larger customer base, across new channels, with a
Biotech company Anjarium Biosciences (Anjarium) has closed a CHF55.5 million (USD61 million) Series A financing, co-led by Abingworth and Gimv, with significant participation from Omega Funds, Pfizer Ventures and Surveyor Capital (a Citadel company).
Anjarium’s innovative approach leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology and nanoparticle engineering to rationally design and produce tissue-targeted gene therapies, optimised to improve patient outcomes in a range of serious genetic diseases.
The Company’s unique platform combines proprietary DNA-based gene vectors, natural and synthetic nanoparticle delivery modalities – including its novel Hybridosome technology – and cost-efficient, scalable manufacturing solutions.
In accordance with a shareholders’ agreement entered into on 10 August 2020, Amber Capital (on behalf of the funds it manages) has informed Vivendi of its intention to sell all of its Lagardère shares to enable Vivendi to exercise, as the case may be, its right of first offer in accordance with the agreement.
In this context, Vivendi made an offer to purchase the 25,305,448 Lagardère shares held by Amber Capital, representing 17.93 per cent of the share capital and 14.34 per cent of the theoretical voting rights of Lagardère, at a price per share of EUR24.10.
This proposal
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
